Huang JA - Search Results

1

The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer.

Zhang N, Zeng Y, Du W, Zhu J, Shen D, Liu Z, Huang JA. Zhang N, et al. Among authors: huang ja. Int J Oncol. 2016 Oct;49(4):1360-8. doi: 10.3892/ijo.2016.3632. Epub 2016 Jul 26. Int J Oncol. 2016. PMID: 27499357

2

Genetic variants in interleukin-6 modified risk of obstructive sleep apnea syndrome.

Zhang X, Liu RY, Lei Z, Zhu Y, Huang JA, Jiang X, Liu Z, Liu X, Peng X, Hu H, Zhang HT. Zhang X, et al. Among authors: huang ja. Int J Mol Med. 2009 Apr;23(4):485-93. doi: 10.3892/ijmm_00000155. Int J Mol Med. 2009. PMID: 19288024

3

Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.

Lu XD, Zhu XL, Chen C, Zhang GB, Zhang XG, Huang JA. Lu XD, et al. Among authors: huang ja. Ai Zheng. 2009 Jan;28(1):20-3. Epub 2009 Jan 12. Ai Zheng. 2009. PMID: 19448410 Free article.

4

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation.

Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. Mu CY, et al. Among authors: huang ja. Med Oncol. 2011 Sep;28(3):682-8. doi: 10.1007/s12032-010-9515-2. Epub 2010 Apr 6. Med Oncol. 2011. PMID: 20373055

5

[Expression of endothelial protein C receptor in tumor cell lines and It's significance].

Heng W, Huang JA, Shen WH, Dai L, Bai X, Wang ZY. Heng W, et al. Among authors: huang ja. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Aug;26(8):761-3. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010. PMID: 20619102 Chinese.

6

[The Expression and Biological Significance of PD-L1 on Lung Cancer Cell Lines.].

Chen C, Mu C, Qu Q, Zhu Y, Sun J, Zhang X, Huang J. Chen C, et al. Zhongguo Fei Ai Za Zhi. 2009 Aug 20;12(8):859-63. doi: 10.3779/j.issn.1009-3419.2009.08.05. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719171 Free article. Chinese.

7

HGFK1 is associated with a better prognosis and reverses inhibition by gefitinib in NSCLC cases.

Zhou XH, Tang LN, Yue L, Min DL, Yang Y, Huang JA, Shen Z. Zhou XH, et al. Among authors: huang ja. Asian Pac J Cancer Prev. 2012;13(4):1457-61. doi: 10.7314/apjcp.2012.13.4.1457. Asian Pac J Cancer Prev. 2012. PMID: 22799348 Free article.

8

Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response.

Chen C, Shen Y, Qu QX, Chen XQ, Zhang XG, Huang JA. Chen C, et al. Among authors: huang ja. Exp Cell Res. 2013 Jan 1;319(1):96-102. doi: 10.1016/j.yexcr.2012.09.006. Epub 2012 Sep 19. Exp Cell Res. 2013. PMID: 22999863

9

Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.

Chen YB, Mu CY, Chen C, Huang JA. Chen YB, et al. Among authors: huang ja. Asia Pac J Clin Oncol. 2014 Jun;10(2):e1-6. doi: 10.1111/ajco.12037. Epub 2012 Nov 21. Asia Pac J Clin Oncol. 2014. PMID: 23167931

10

Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study.

Chen YB, Mu CY, Huang JA. Chen YB, et al. Among authors: huang ja. Tumori. 2012 Nov;98(6):751-5. doi: 10.1177/030089161209800612. Tumori. 2012. PMID: 23389362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters